Bantounou, Maria AnnaSardellis, PanagiotisPlascevic, JosipAwaes-Mahmood, RibeyaKaczmarek, JustynaBlack Boada, DanielThuemmler, RosaPhilip, Sam2025-03-172025-03-172025-04Bantounou, M A, Sardellis, P, Plascevic, J, Awaes-Mahmood, R, Kaczmarek, J, Black Boada, D, Thuemmler, R & Philip, S 2025, 'Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes', ESC Heart Failure, vol. 12, no. 2, pp. 968-979. https://doi.org/10.1002/ehf2.150362055-5822ORCID: /0000-0001-6164-211X/work/171446483https://hdl.handle.net/2164/25149121359544engSDG 3 - Good Health and Well-beingheart failuremeta-analysissodium-glucose co-transporter 1 (SGLT1)sodium-glucose co-transporter 2 (SGLT2)sotagliflozintype 2 diabetes mellitusR MedicineCardiology and Cardiovascular MedicineSupplementary DataDASSupplementary InformationRMeta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetesJournal item10.1002/ehf2.15036http://www.scopus.com/inward/record.url?scp=85203444964&partnerID=8YFLogxK122